Flexadin UCII Promotes Cartilage Development and Joint Health in Horses

LEXINGTON, KY, May 2, 2017 – Vetoquinol USA™ (www.BarnChats.com), a world-class developer of veterinarian-approved formulas for large animal healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at last week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin UCII promotes cartilage development and joint health in horses at the immunologic level.

The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and joints. Its unique, patented collagen ingredient interacts with the digestive system to support joint integrity. With once daily administration, backed by a comparison study in horses, it improves flexibility, mobility and physical activity. The easy-to-administer and palatable banana-flavored powder stops the immune system from attacking and damaging its own joint cartilage.

“We are proud to finally be able to offer this exceptional product to riders in the United States,” explains Tabitha Cromer, marketing manager at Vetoquinol. “In the equine industry, horse owners and caretakers are looking for products that improve their horse’s quality of life, keep their horses healthy and reduce discomfort. This year we’re thrilled to introduce Flexadin UCII as part of our corporate sponsorship at the Rolex Kentucky. ”
Flexadin UCII is available through veterinary offices. To learn more about Flexadin UCII and Vetoquinol USA, visit www.barnchats.com